MedAdvisor has announced
closure of its public fund-raising for
their ASX listing with subscriptions
exceeding the maximum limit of
$5m.
Pharmacists were protected from
scale back through the MedAdvisor
Pharmacy Priority Offer, the
company said.
The offer drew strong support
from a wide range of investors, with
16% of investment coming from
pharmacies and pharmacy groups
nationwide.
Interested pharmacists who
missed out on the public offering
can invest in MedAdvisor when it
commences trading as MedAdvisor
(ASX:MDR) in Nov 2015.
MedAdvisor is the most
downloaded Australian (Apple and
Android) medication-related app.The above article was sent to subscribers in Pharmacy Daily's issue from 20 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Oct 15
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.